
CASE Op-Ed – Naples Daily News: Congress Must Pass Market-Based Approach to Address Surprise Billing
December 19, 2019 Surprise medical billing creates undue financial hardships for patients and their families at a time when all...
December 19, 2019 Surprise medical billing creates undue financial hardships for patients and their families at a time when all...
December 19, 2019 Today, the Food and Drug Administration (FDA) issued a notice of proposed rulemaking to allow the importation...
December 11, 2019 In what could be the policy hallmark of his first term in office, President Trump has...
December 5, 2019 Click Here to see full coalition letter. Text of Letter: We represent fiscal conservatives and free...
December 4, 2019 A new report issued this week by the President’s Council of Economic Advisers (CEA) provides a startling snapshot of...
“I don’t think people would be supportive of this idea if they realized there would be so many fewer cures.”...
Matthew Kandrach – President, CASE November 7, 2019 Few policy issues have consumed Washington more over the past year...
This month, millions of seniors will take advantage of the Medicare open enrollment period, shopping for Medicare Advantage and Medicare...
Gerard Scimeca – Chairman, CASE October 8, 2019 There is an impulse among some lawmakers that whatever the problem, more...
Gerard Scimeca – Chairman, CASE October 4, 2019 America has long led the world in groundbreaking innovation and life-altering inventions....
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/
© 2025 · Case for Consumers